Clade Ib: a new emerging threat in the Mpox outbreak
Frontiers in Pharmacology · 19.12.2024 · 15
DOI: 10.3389/fphar.2024.1504154 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Pharmacology, online erschienen am 19.12.2024. Verfasst von Shriyansh Srivastava und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, School of Medical and Allied Sciences, Galgotias University, Greater Noida, India. Die Arbeit wurde bisher 59-mal zitiert (Crossref) und nennt 153 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Monkeypox, a zoonotic virus in the Orthopoxvirus genus , has drawn global attention for its impact on public health. In the current Mpox outbreak, a novel clade, Ib, has emerged as a significant and potentially fatal threat. This review examines the dynamics of MPXV transmission, person-to-person spread, and infection mechanisms, highlighting key risk factors. We explore the clinical features of Mpox, focusing on symptomology, illness duration, and the distinguishing characteristics of clade Ib compared to other clades. A critical analysis addresses diagnostic techniques and emphasizes the need for robust surveillance, particularly for clade Ib detection. We review recent prevention and treatment strategies, including antiviral drugs and vaccines, with a focus on clade Ib containment. The conclusion underscores the urgency of global collaboration to prevent and prepare for emerging threats like clade Ib and identifies crucial research paths and knowledge gaps. This review offers a comprehensive overview of clade Ib, covering its emergence, genetic traits, epidemiological impact, transmission patterns, clinical features, the role of Artificial Intelligence (AI) in outbreak management, detection challenges, and implications for public health response.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmacy, School of Medical and Allied Sciences, Galgotias University, Greater Noida, India.
- Department of Pharmacology, Delhi Pharmaceutical Sciences and Research University (DPSRU), New Delhi, India.
- RAK College of Pharmacy, RAK Medical and Health Sciences University, Ras Al Khaimah, United Arab Emirates.
- Dr. Lal PathLabs Nepal, Kathmandu, Nepal.
- Clinical Microbiology, RDC, Manav Rachna International Institute of Research and Studies, Faridabad, Haryana, India.
- Center for Global Health Research, Saveetha Medical College and Hospital, Chennai, Tamil Nadu, India.
Zitieren
APA
Srivastava, S., Laxmi, Sharma, K., Sridhar, S. B., Talath, S., Shareef, J., Mehta, R., Satapathy, P., & Sah, R. (2024). Clade Ib: a new emerging threat in the Mpox outbreak. Frontiers in Pharmacology, 15. https://doi.org/10.3389/fphar.2024.1504154
Vancouver
Srivastava S, Laxmi, Sharma K, Sridhar SB, Talath S, Shareef J, et al. Clade Ib: a new emerging threat in the Mpox outbreak. Frontiers in Pharmacology. 2024;15. doi:10.3389/fphar.2024.1504154
BibTeX
@article{Srivastava2024,
author = {Srivastava, Shriyansh and Laxmi and Sharma, Khyati and Sridhar, Sathvik Belagodu and Talath, Sirajunisa and Shareef, Javedh and Mehta, Rachana and Satapathy, Prakisini and Sah, Ranjit},
title = {Clade Ib: a new emerging threat in the Mpox outbreak},
journal = {Frontiers in Pharmacology},
year = {2024},
volume = {15},
doi = {10.3389/fphar.2024.1504154}
}
EUVIMED